ProMIS Neurosciences (PMN) Stock Statistics & Valuation Metrics

ProMIS Neurosciences has a market cap or net worth of $16.79M. The enterprise value is $3.12M.

ProMIS Neurosciences has 32,689,190 shares outstanding. The number of shares has decreased by -2.65% in one year.

ProMIS Neurosciences’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is -33850.63%.

The current PE Ratio of ProMIS Neurosciences is <0.01. ProMIS Neurosciences’s PEG ratio is 0.05.

In the last 12 months, ProMIS Neurosciences had revenue of 0.00 and earned 2.78B in profits. Earnings per share was 0.11.

In the last 12 months, operating cash flow was -27.10M and capital expenditures 0.00, giving a free cash flow of -27.10M billion.

ProMIS Neurosciences pays an annual dividend of ―, resulting in a dividend yield of ―

ProMIS Neurosciences upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.

ProMIS Neurosciences as a current ratio of 8.52, with Debt / Equity ratio of 0.00%

In the past 12 months, ProMIS Neurosciences has paid 0.00 in taxes.

ProMIS Neurosciences EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -0.41.

ProMIS Neurosciences has $13.32M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$13.32M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for ProMIS Neurosciences is $4.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy